Holen Sie sich die Stockscreener-App
13.95
0.96%
-0.135
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$14.08
Offen:
$14.01
24-Stunden-Volumen:
1.33M
Relative Volume:
0.45
Marktkapitalisierung:
$2.76B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-6.7367
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
+0.54%
1M Leistung:
+2.69%
6M Leistung:
-40.38%
1J Leistung:
-50.71%
1-Tages-Spanne:
$13.72
$14.03
1-Wochen-Bereich:
$13.38
$14.30
52-Wochen-Spanne:
$12.16
$29.13
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
13.94 | 2.76B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
534.28 | 184.23B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
168.15 | 48.46B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
97.94 | 47.15B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
240.92 | 35.24B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.06 | 16.39B | 3.90B | 392.30M | 288.10M | 1.95 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock? - TradingView
Clear Aligners Market Size Projected to Surge $21.75 - GlobeNewswire
Dental Implantology Software Market Size to Hit USD 393.57 Mn by 2034 - Precedence Research
Gum Grafting Market Size, Share & Trends Analysis Report 2025-2032|Straumann Group,Dentsply Sirona - openPR.com
Digital Orthodontics Market to Hit $22.95 Billion by 2033 | CAGR - openPR.com
Gingival Recession Market Growth 2025: Trends, Consumer - openPR.com
DENTSPLY SIRONA (NASDAQ:XRAY) Sets New 52-Week Low on Analyst Downgrade - Defense World
DENTSPLY Sirona Inc (XRAY): Hold On When You’re Right - Stocksregister
Press Release Distribution & PR Platform - ACCESS Newswire
Earnings Preview: Dentsply International (XRAY) Q1 Earnings Expected to Decline - Nasdaq
DENTSPLY Sirona Inc (XRAY) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
DENTSPLY Sirona Inc [XRAY] Records 50-Day SMA of $15.14 - knoxdaily.com
DENTSPLY SIRONA (XRAY) to Release Quarterly Earnings on Thursday - Defense World
XRAY’s valuation metrics: A comprehensive analysis - uspostnews.com
Dentsply Sirona to replace Connect Case Center with DS Core cloud platform by November - Oral Health Group
Is DENTSPLY Sirona Inc (NASDAQ: XRAY) Stock Poised for More Growth? - Marketing Sentinel
Tooth Replacement Market to Witness Remarkable Growth with - openPR.com
Dentsply Sirona (XRAY) Faces Reduced Price Target Amid Market Ch - GuruFocus
Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden - simplywall.st
Dental Burs Market Report: Growth Drivers and Challenges 2025 & - openPR.com
Dental Laboratories Market Projected To Witness Substantial - openPR.com
Nothing is Better Than DENTSPLY Sirona Inc (XRAY) stock at the moment - Sete News
3D Cbct System Market to Set Phenomenal Growth From 2025 to 2034 | Carestream Dental,Planmeca,Dentsply Sirona - openPR.com
Personalized Orthodontic Devices Market: Revenue Growth - openPR.com
XRAY’s latest rating updates from top analysts. - knoxdaily.com
Q4 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks - Yahoo Finance
Levi & Korsinsky Reminds Dentsply Sirona Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 27, 2025XRAY - ACCESS Newswire
Dentures Market Projected To Witness Substantial Growth, - openPR.com
Cosmetic Dentistry Market Overall Study Report 2025-2032 | - openPR.com
DENTSPLY Sirona Inc [XRAY] Records 50-Day SMA of $15.61 - knoxdaily.com
The Significance of Moving Averages in DENTSPLY Sirona Inc Inc. (XRAY) Price Performance - investchronicle.com
Mizuho Adjusts Dentsply Sirona (XRAY) Price Target to $16 Amid S - GuruFocus
Wells Fargo & Company MN Reduces Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) - Defense World
Orthodontic Product Market to See Huge Growth by 2032 | Align Technology, 3M, Dentsply Sirona - openPR.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Investors to Reach Out - markets.businessinsider.com
Clear Aligners Market Size, Share & Trends Analysis Report - openPR.com
Osseointegration Implants Market Set to Witness Significant Growth by 2025-2032 | 3M, Zimmer Biomet, Dentsply Sirona - openPR.com
Dental Digital X-Ray Market Report 2025, with Dentsply Sirona, Envista Holdings, Acteon Group, Planmeca and Varex Imaging - GlobeNewswire Inc.
Electric Dental Handpiece Market Projected To Witness - openPR.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Reach Out - markets.businessinsider.com
Envestnet Asset Management Inc. Buys 71,213 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) - Defense World
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Digital Denture (Tubes, Tips, Restractors, Cannulae) Market by Usability (Disposable, Reusable), Application (General Surgery, Neurosurgery, Orthopedic, Cardiovascular, Dental) - GlobeNewswire Inc.
Intraoral Scanning And Inspection System Market Overall Study - openPR.com
XRAY Investors Have Opportunity to Lead Dentsply Sirona Inc. Securities Fraud Lawsuit (PR Newswire) - Aktiellt
Dentsply Sirona: Trimming Valuation on Tariff Uncertainty and Likely Ensuing Industry Slowdown - Morningstar
Macro Challenges, Tariff Uncertainty, and Soft Demand Throw a Wrench in Dentsply's Recovery - Morningstar
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):